Steba Biotech's TOOKAD(R) Vascular Photodynamic Therapy Maintains Significant Reduction in Overall Progression and Conversion to Radical Therapy in Low-risk Prostate Cancer Patients at 4 Years

LUXEMBOURG, June 20, 2018 -- (Healthcare Sales & Marketing Network)-- Steba Biotech, a privately-owned biotechnology company focused on the development of innovative and minimally invasive photodynamic therapies and systems to treat cancers, today announ...Biopharmaceuticals,Urology, Oncology
Steba Biotech, photodynamic therapy, TOOKAD, prostate cancer